• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

My Pulmonary Hypertension Journey

February 21, 2013 By Dr. Jeremy Feldman

PAH patient storyEvery patient I have met in our pulmonary hypertension clinic has one thing in common; their journey to diagnosis and treatment for their pulmonary arterial hypertension has been long and frustrating.  The average time from symptom onset to diagnosis is two and a half years!  Below is the story of what one patient, we will call her Mrs. X, went through.

Mrs. X started experiencing somewhat vague symptoms of fatigue or shortness of breath when walking up inclines and stairs.  She made an appointment with her primary care physician to discuss her symptoms. She was told that she was overweight and depressed. She did not improve after several months and she was referred to a pulmonologist.

Her pulmonologist was not a pulmonary arterial hypertension expert but working with a cardiologist did perform an echocardiogram,  pulmonary function tests, and a right heart catheterization.  She was diagnosed with pulmonary arterial hypertension and started on a calcium channel blocker with some improvement.  She had another right heart catheterization that same year and was started on an endothelin receptor antagonist.  She began feeling worse.  Eventually she was started on an inhaled prostacyclin.  She had been very active and exercised regularly up until this point but felt so terrible after starting the prostacyclin she could no longer exercise.  This continued for several years and eventually Mrs. X was told that she would need a lung transplant.

We met Mrs. X and her family at an educational dinner event where Dr. Feldman and I were speaking.  After our presentation the patient and family approached me and told me her story.  They did not realize there were physicians out there that specialize in pulmonary arterial hypertension.  They asked if she could be seen at our clinic for a second opinion.  Records were requested and an appointment was set.

Dr. Feldman reviewed Mrs. X’s records and although all of the correct testing to diagnose pulmonary hypertension had been performed and even repeated several times, the results were not consistent with a diagnosis of pulmonary arterial hypertension.  Mrs. X had diastolic heart failure.  Endothelin receptor antagonists and prostacyclin therapies are known to make this disease worse.

Mrs. X had been misdiagnosed for nearly 10 years by the time we met her.  She had felt worse with each additional therapy that was added for her PH.  She had to stop exercising and was eventually told that she would die without lung transplantation.  For Mrs. X a second opinion by a pulmonary hypertension expert gave her back her life.  The PH medications she had been prescribed were discontinued, diuretics, a low salt diet and fluid restriction were initiated.  When Mrs. X came back several weeks later she bounced into the office with a big smile.  She was back to exercising regularly and very optimistic about her future.

Mrs. X’s story demonstrates that it is just as dangerous to be misdiagnosed with pulmonary hypertension as to not be diagnosed correctly when you do have the disease.  So what is the pulmonary hypertension community doing about this?  Many physicians and nurses specializing in pulmonary hypertension participate in events that focus on educating community physicians.  These events range from large formal continuing education events to small dinner conversations.  The goal is to recognize the warning signs of PH early and treat or refer to a specialist.  Pulmonary hypertension support groups also put on fundraisers to raise awareness and funds for research.  The Pulmonary Hypertension Association, www.phassociation.org, hosts educational events across the country for patients and healthcare professionals.  Working together we hope to decrease the time from symptom onset to diagnosis and stop misdiagnosis altogether.

Filed Under: Blog, Home Page, Pulmonary Hypertension Diagnosis

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

pulmonary hypertension research laboratory

Serotonin and Pulmonary Arterial Hypertension

By Dr. Jeremy Feldman

Serotonin is an important molecule in our bodies.  It works in our brain to regulate mood, appetite, sleep,

Pulmonary hypertension and pregnancy

Eisenmenger’s Syndrome

By Dr. Jeremy Feldman

Congenital Heart Disease & Eisenmenger's Syndrome February 4th-7th is Congenital Heart Disease Awareness week.  The

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives